Design, Synthesis, and Xanthine Oxidase Inhibitory Activity of 4‐(5‐Aminosubstituted‐4‐cyanooxazol‐2‐yl)benzoic Acids
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400478 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Oleksandr Kobzar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioorganic Mechanisms, V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Sciences of Ukraine…. Hauptthemen laut MEDLINE: Xanthine Oxidase, Enzyme Inhibitors, Drug Design, Molecular Docking Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Academy of Sciences of Ukraine.
Abstract (Originalsprache)
Xanthine oxidase is a known therapeutic target for the treatment of hyperuricemia and related diseases. Despite the availability of current drugs such as allopurinol and febuxostat, the search for new compounds to effectively inhibit this enzyme remains relevant. In our study, 75 virtual structures of 4‐(5‐aminosubstituted‐4‐cyanooxazol‐2‐yl)benzoic acids with structural similarity to febuxostat were designed for evaluation of their potency against xanthine oxidase. After molecular docking simulations, eight compounds were selected for synthesis and in vitro testing. The synthesized compounds were found to exhibit in vitro xanthine oxidase inhibitory activity in the nanomolar concentration range. The most effective inhibitors with 4‐benzylpiperidin‐1‐yl or 1,2,3,4‐tetrahydroisoquinolin‐2‐yl substituents at position 5 of the oxazole ring had IC 50 values close to that of febuxostat. The kinetic data suggest a mixed‐type inhibition when the inhibitor binds preferentially to the free enzyme rather than to the enzyme‐substrate complex. Molecular docking and molecular dynamic simulations were carried out to get insight into the key interactions of the inhibitors bound to the xanthine oxidase active site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioorganic Mechanisms, V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Sciences of Ukraine, Academika Kukharya Str. 1, 02094, Kyiv, Ukraine.
- Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V. P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the National Academy of Sciences of Ukraine, Academika Kukharya Str. 1, 0…
- Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Akadeemia tee 23, 12618, Tallinn, Estonia.
ORCID-Profile: Oleksandr Kobzar, Alona Beiko, Danylo Merzhyievskyi, Oleg Shablykin, Volodymyr Brovarets, Vsevolod Tanchuk, Andriy Vovk
Förderung
- National Academy of Sciences of Ukraine
Zitieren
APA
Kobzar, O., Beiko, A., Merzhyievskyi, D., Shablykin, O., Brovarets, V., Tanchuk, V., & Vovk, A. (2024). Design, Synthesis, and Xanthine Oxidase Inhibitory Activity of 4‐(5‐Aminosubstituted‐4‐cyanooxazol‐2‐yl)benzoic Acids. ChemMedChem. https://doi.org/10.1002/cmdc.202400478
Vancouver
Kobzar O, Beiko A, Merzhyievskyi D, Shablykin O, Brovarets V, Tanchuk V, et al. Design, Synthesis, and Xanthine Oxidase Inhibitory Activity of 4‐(5‐Aminosubstituted‐4‐cyanooxazol‐2‐yl)benzoic Acids. ChemMedChem. 2024. doi:10.1002/cmdc.202400478
BibTeX
@article{Kobzar2024,
author = {Kobzar, Oleksandr and Beiko, Alona and Merzhyievskyi, Danylo and Shablykin, Oleg and Brovarets, Volodymyr and Tanchuk, Vsevolod and Vovk, Andriy},
title = {Design, Synthesis, and Xanthine Oxidase Inhibitory Activity of 4‐(5‐Aminosubstituted‐4‐cyanooxazol‐2‐yl)benzoic Acids},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400478}
}
EUVIMED